NCT04103021 is a NA clinical trial of Port-A-Cath in Cancer, sponsored by Omar Mokhtar Hussein.

Who is sponsoring NCT04103021?

NCT04103021 is sponsored by Omar Mokhtar Hussein.

What drugs are being tested in NCT04103021?

Interventions in NCT04103021: Port-A-Cath.

Is NCT04103021 still recruiting?

NCT04103021 is currently status unknown. Last updated 25 September 2019.

Last reviewed 2019-09-25 · How we verify

NCT04103021

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ultrasound Guided Port-A-Cath Isertion in Cancer Patients

Status unknown NA Last updated 25 September 2019

What this trial tests

NA trial testing Port-A-Cath in Cancer in 20 participants. Status unknown.

Timeline

30 October 2019

Primary endpoint
30 October 2020

30 October 2020

Quick facts

Lead sponsor	Omar Mokhtar Hussein
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	20
Start date	30 October 2019
Primary completion	30 October 2020
Estimated completion	30 October 2020

Drugs / interventions tested

Port-A-Cath

Conditions studied

Cancer — all drugs for Cancer →

Sponsor

Omar Mokhtar Hussein

Who can join

Eligibility, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Port-A-Cath is a totally implanted central venous access system and one of the most frequently used systems for administration of chemotherapies in oncological patients . The currently used techniques for placement of totally implantable venous access devices involve the open insertion by cut down technique, or percutaneous puncture of the central vein either by anatomical landmarks or image guided approach by using ultrasound guidance which is increasingly being preferred over the traditional anatomical landmark due to its low complication rate and high technical success rate; as this technique enables the direct visualization of needle entrance and advancement into the target vein

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cancer

Currently open trials in the same condition.

NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04103021 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Omar Mokhtar Hussein
Last refreshed: 25 September 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04103021.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing